VITILIGO-BEHANDLUNG
European patent · EP2957292 · In force
Register entry
- Publication number
- EP2957292
- Application number
- EP15170572
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 27, 2009
- Published
- Dec 23, 2015
- Granted
- Dec 13, 2017
- Protection ends at the latest
- Mar 26, 2029
- Next annual fee due
- Mar 31, 2027
- IPC classes
- A61K 38/13 (2006.01)A61K 38/21 (2006.01)A61K 38/34 (2006.01)A61K 9/00 (2006.01)A61K 31/37 (2006.01)A61K 31/436 (2006.01)A61K 31/485 (2006.01)A61K 31/505 (2006.01)A61K 31/52 (2006.01)A61K 31/573 (2006.01)A61K 31/58 (2006.01)A61K 45/06 (2006.01)A61N 5/06 (2006.01)C07K 14/685 (2006.01)A61P 17/00 (2006.01)
- Priority
- AU 2008901461 27.03.2008
- Divided from
- EP09726233
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
- Sep 8, 2025
Transferred
- Owner
- Clinuvel Pharmaceuticals Limited, Level 6, 15 Queen Street, Melbourne, VIC 3000, Australia → CLINUVEL INC., 1825 S. Grant Street, Suite 200, San Mateo, CA 94402, USA
Published in Swissreg on 08.09.2025
- Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
- Apr 23, 2024
Change
Published in Swissreg on 23.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Feb 23, 2018
Agent entered
- Representative
- MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex
Published in Swissreg on 23.02.2018
- Dec 13, 2017
Granted
Published in Swissreg on 13.12.2017
Parties
Inventor
Wolgen, Philippe
Melbourne, Victoria 3000, AU
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.